Real-World Study Confirms Efficacy of Venetoclax Alone, After BTKi Therapy in CLL
Researchers found that venetoclax, either alone or post treatment with a Bruton tyrosine kinase inhibitor (BTKi), was safe and effective for patients with chronic lymphocytic leukemia (CLL).
Source: ajmc.com